Cervical cancer: Navigating today’s global clinical trial landscape
A new report from leading contract research organisation Novotech has shed light on the current state of play in the…
A new report from leading contract research organisation Novotech has shed light on the current state of play in the…
Artificial intelligence (AI) is set to be the most disruptive emerging technology in drug development in 2023, unlocking advanced analytics,…
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast…